1. aleciaax
2. artiestroke
3. sealdog555
1.artiestroke 06/15/2018
Kitov Announces Positive Pre-clinical Data from NT219 Demonstrating its Dose-Dependent Anti-Tumor Efficacy
2.aleciaax 03/05/2018
Kitov Pharmaceuticals Publishes Annual Report for 2017 and Issues CEO Letter to Shareholders
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW